Cite
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
MLA
Deborah P. Lubeck, et al. “Quality Adjusted Life Year Gains Associated with Administration of Recombinant Tissue-Type Plasminogen Activator for Treatment of Acute Ischemic Stroke: 1998-2011.” International Journal of Stroke, vol. 11, no. 2, Feb. 2016, pp. 198–205. EBSCOhost, https://doi.org/10.1177/1747493015609776.
APA
Deborah P. Lubeck, Danese, M. D., Duryea, J., Halperin, M., Tayama, D., Yu, E., Lalla, D., & Grotta, J. C. (2016). Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011. International Journal of Stroke, 11(2), 198–205. https://doi.org/10.1177/1747493015609776
Chicago
Deborah P. Lubeck, Mark D. Danese, Jennifer Duryea, Marc Halperin, Darren Tayama, Elaine Yu, Deepa Lalla, and James C. Grotta. 2016. “Quality Adjusted Life Year Gains Associated with Administration of Recombinant Tissue-Type Plasminogen Activator for Treatment of Acute Ischemic Stroke: 1998-2011.” International Journal of Stroke 11 (2): 198–205. doi:10.1177/1747493015609776.